Inhibiting oxidative phosphorylation in vivo restrains Th17 effector responses and ameliorates murine colitis

Journal of Immunology

Volumn 198, Issue 7, 2017, Pages 2735-2746

  Franchi, Luigi ^a   Monteleone, Ivan ^b   Hao, Ling Yang ^c   Spahr, Mark A ^c   Zhao, Wenpu ^a   Liu, Xikui ^c   Demock, Kellie ^c   Kulkarni, Aditi ^c   Lesch, Chuck A ^c   Sanchez, Brian ^c   Carter, Laura ^c   Marafini, Irene ^b   Hu, Xiao ^c   Mashadova, Oksana ^d   Yuan, Min ^e   Asara, John M ^f   Singh, Harinder ^g   Lyssiotis, Costas A ^a   Monteleone, Giovanni ^b   Opipari, Anthony W ^a   Glick, Gary D ^h   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Lycera Corporation   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; SMALL INTERFERING RNA; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SELECTION; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GLYCOLYSIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE BIOPSY; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; METABOLIC STRESS; METABOLOMICS; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH17 CELL; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL SEPARATION; DISEASE MODEL; DNA MICROARRAY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; TH17 CELLS; TRANSCRIPTOME;

EID: 85016283066     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600810     Document Type: Article

References (68)

1. Pearce, E. L., and E. J. Pearce. 2013. Metabolic pathways in immune cell activation and quiescence. Immunity 38: 633-643.
2. MacIver, N. J., R. D. Michalek, and J. C. Rathmell. 2013. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31: 259-283.
3. Wahl, D. R., C. A. Byersdorfer, J. L. Ferrara, A. W. Opipari, Jr., and G. D. Glick. 2012. Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunol. Rev. 249: 104-115.
4. O'Sullivan, D., and E. L. Pearce. 2015. Targeting T cell metabolism for therapy. Trends Immunol. 36: 71-80.
5. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
6. Huber, S., N. Gagliani, and R. A. Flavell. 2012. Life, death, and miracles: Th17 cells in the intestine. Eur. J. Immunol. 42: 2238-2245.
7. O'Connor Jr., W., L. A. Zenewicz, and R. A. Flavell. 2010. The dual nature of TH17 cells: shifting the focus to function. Nat. Immunol. 11: 471-476.
8. Lee, Y., A. Awasthi, N. Yosef, F. J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13: 991-999.
9. Zielinski, C. E., F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto. 2012. Pathogeninduced human TH17 cells produce IFN-g or IL-10 and are regulated by IL-1b. Nature 484: 514-518.
10. Hu, X., Y.Wang, L. Y. Hao, X. Liu, C. A. Lesch, B. M. Sanchez, J. M.Wendling, R. W. Morgan, T. D. Aicher, L. L. Carter, et al. 2015. Corrigendum: sterol metabolism controls TH17 differentiation by generating endogenous RORg agonists. Nat. Chem. Biol. 11: 741.
11. Semenza, G. L. 2011. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 76: 347-353.
12. Saunier, E., C. Benelli, and S. Bortoli. 2016. The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents. Int. J. Cancer 138: 809-817.
13. Shi, L. Z., R. Wang, G. Huang, P. Vogel, G. Neale, D. R. Green, and H. Chi. 2011. HIF1a-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208: 1367-1376.
14. Michalek, R. D., V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. MacIver, E. F. Mason, S. A. Sullivan, A. G. Nichols, and J. C. Rathmell. 2011. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186: 3299-3303.
15. Delgoffe, G. M., K. N. Pollizzi, A. T. Waickman, E. Heikamp, D. J. Meyers, M. R. Horton, B. Xiao, P. F. Worley, and J. D. Powell. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12: 295-303.
16. Gerriets, V. A., R. J. Kishton, A. G. Nichols, A. N. Macintyre, M. Inoue, O. Ilkayeva, P. S. Winter, X. Liu, B. Priyadharshini, M. E. Slawinska, et al. 2015. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125: 194-207.
17. Dang, E. V., J. Barbi, H. Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, H. R. Yen, et al. 2011. Control of TH17/Treg balance by hypoxiainducible factor 1. Cell 146: 772-784.
18. Berod, L., C. Friedrich, A. Nandan, J. Freitag, S. Hagemann, K. Harmrolfs, A. Sandouk, C. Hesse, C. N. Castro, H. Bähre, et al. 2014. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20: 1327-1333.
19. Pollizzi, K. N., and J. D. Powell. 2014. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14: 435-446.
20. Pearce, E. L., M. C. Poffenberger, C. H. Chang, and R. G. Jones. 2013. Fueling immunity: insights into metabolism and lymphocyte function. Science 342: 1242454.
21. Gatza, E., D. R. Wahl, A. W. Opipari, T. B. Sundberg, P. Reddy, C. Liu, G. D. Glick, and J. L. Ferrara. 2011. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci. Transl. Med. 3: 67ra8.
22. Procaccini, C., F. Carbone, D. Di Silvestre, F. Brambilla, V. De Rosa, M. Galgani, D. Faicchia, G. Marone, D. Tramontano, M. Corona, et al. 2016. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. [Published erratum appears in 2016 Immunity 44: 712.] Immunity 44: 406-421.
23. Monteleone, G., L. Biancone, R. Marasco, G. Morrone, O. Marasco, F. Luzza, and F. Pallone. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112: 1169-1178.
24. Son, J., C. A. Lyssiotis, H. Ying, X. Wang, S. Hua, M. Ligorio, R. M. Perera, C. R. Ferrone, E. Mullarky, N. Shyh-Chang, et al. 2013. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496: 101-105.
25. Yuan, M., S. B. Breitkopf, X. Yang, and J. M. Asara. 2012. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7: 872-881.
26. Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. van der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.
27. Glick, G. D., R. Rossignol, C. A. Lyssiotis, D. Wahl, C. Lesch, B. Sanchez, X. Liu, L. Y. Hao, C. Taylor, A. Hurd, et al. 2014. Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. J. Pharmacol. Exp. Ther. 351: 298-307.
28. Berridge, M. V., P. M. Herst, and A. S. Tan. 2010. Metabolic flexibility and cell hierarchy in metastatic cancer. Mitochondrion 10: 584-588.
29. Viale, A., P. Pettazzoni, C. A. Lyssiotis, H. Ying, N. Sánchez, M. Marchesini, A. Carugo, T. Green, S. Seth, V. Giuliani, et al. 2014. Oncogene ablationresistant pancreatic cancer cells depend on mitochondrial function. Nature 514: 628-632.
30. Ellouz, F., A. Adam, R. Ciorbaru, and E. Lederer. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59: 1317-1325.
31. Adam, A., R. Ciorbaru, F. Ellouz, J. F. Petit, and E. Lederer. 1974. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem. Biophys. Res. Commun. 56: 561-567.
32. Chatterjee, S., K. Thyagarajan, P. Kesarwani, J. H. Song, M. Soloshchenko, J. Fu, S. R. Bailey, C. Vasu, A. S. Kraft, C. M. Paulos, et al. 2014. Reducing CD73 expression by IL1b-programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 74: 6048-6059.
33. Ray, J. P., M. M. Staron, J. A. Shyer, P. C. Ho, H. D. Marshall, S. M. Gray, B. J. Laidlaw, K. Araki, R. Ahmed, S. M. Kaech, and J. Craft. 2015. The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43: 690-702.
34. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
35. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
36. Wang, H., H. Flach, M. Onizawa, L. Wei, M. T. McManus, and A. Weiss. 2014. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 15: 393-401.
37. Zúñiga, L. A., R. Jain, C. Haines, and D. J. Cua. 2013. Th17 cell development: from the cradle to the grave. Immunol. Rev. 252: 78-88.
38. Krauss, S., M. D. Brand, and F. Buttgereit. 2001. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 15: 497-502.
39. Xu, T., X. Wang, B. Zhong, R. I. Nurieva, S. Ding, and C. Dong. 2011. Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgt protein. J. Biol. Chem. 286: 22707-22710.
40. Jin, Y., Y. Lin, L. Lin, and C. Zheng. 2012. IL-17/IFN-g interactions regulate intestinal inflammation in TNBS-induced acute colitis. J. Interferon Cytokine Res. 32: 548-556.
41. Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V. R. Jala, H. G. Zhang, T. Wang, J. Zheng, and J. Yan. 2011. Pivotal role of dermal IL-17-producing gd T cells in skin inflammation. Immunity 35: 596-610.
42. Pantelyushin, S., S. Haak, B. Ingold, P. Kulig, F. L. Heppner, A. A. Navarini, and B. Becher. 2012. Rorgt+ innate lymphocytes and gd T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122: 2252-2256.
43. Chang, J. T., E. J. Wherry, and A. W. Goldrath. 2014. Molecular regulation of effector and memory T cell differentiation. Nat. Immunol. 15: 1104-1115.
44. Tripmacher, R., T. Gaber, R. Dziurla, T. Häupl, K. Erekul, A. Grützkau, M. Tschirschmann, A. Scheffold, A. Radbruch, G. R. Burmester, and F. Buttgereit. 2008. Human CD4+ T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur. J. Immunol. 38: 1631-1642.
45. Siska, P. J., and J. C. Rathmell. 2015. T cell metabolic fitness in antitumor immunity. Trends Immunol. 36: 257-264.
46. Doedens, A. L., A. T. Phan, M. H. Stradner, J. K. Fujimoto, J. V. Nguyen, E. Yang, R. S. Johnson, and A. W. Goldrath. 2013. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14: 1173-1182.
47. Gubser, P. M., G. R. Bantug, L. Razik, M. Fischer, S. Dimeloe, G. Hoenger, B. Durovic, A. Jauch, and C. Hess. 2013. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14: 1064-1072.
48. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
49. Pearce, E. L., M. C. Walsh, P. J. Cejas, G. M. Harms, H. Shen, L. S. Wang, R. G. Jones, and Y. Choi. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
50. Kryczek, I., E. Zhao, Y. Liu, Y. Wang, L. Vatan, W. Szeliga, J. Moyer, A. Klimczak, A. Lange, and W. Zou. 2011. Human TH17 cells are long-lived effector memory cells. Sci. Transl. Med. 3: 104ra100.
51. Muranski, P., Z. A. Borman, S. P. Kerkar, C. A. Klebanoff, Y. Ji, L. Sanchez-Perez, M. Sukumar, R. N. Reger, Z. Yu, S. J. Kern, et al. 2011. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35: 972-985.
52. Sukumar, M., J. Liu, Y. Ji, M. Subramanian, J. G. Crompton, Z. Yu, R. Roychoudhuri, D. C. Palmer, P. Muranski, E. D. Karoly, et al. 2013. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123: 4479-4488.
53. Kawalekar, O. U., R. S. O'Connor, J. A. Fraietta, L. Guo, S. E. McGettigan, A. D. Posey, Jr., P. R. Patel, S. Guedan, J. Scholler, B. Keith, et al. 2016. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. [Published erratum appears in 2016 Immunity 44: 712.] Immunity 44: 380-390.
54. Gattinoni, L., C. A. Klebanoff, and N. P. Restifo. 2012. Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer 12: 671-684.
55. Sharon, G., N. Garg, J. Debelius, R. Knight, P. C. Dorrestein, and S. K. Mazmanian. 2014. Specialized metabolites from the microbiome in health and disease. Cell Metab. 20: 719-730.
56. De Rosa, V., M. Galgani, A. Porcellini, A. Colamatteo, M. Santopaolo, C. Zuchegna, A. Romano, S. De Simone, C. Procaccini, C. La Rocca, et al. 2015. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16: 1174-1184.
57. Semenza, G. L. 2013. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Invest. 123: 3664-3671.
58. Patel, M. S., N. S. Nemeria, W. Furey, and F. Jordan. 2014. The pyruvate dehydrogenase complexes: structure-based function and regulation. J. Biol. Chem. 289: 16615-16623.
59. Kaplon, J., L. Zheng, K. Meissl, B. Chaneton, V. A. Selivanov, G. Mackay, S. H. van der Burg, E. M. Verdegaal, M. Cascante, T. Shlomi, et al. 2013. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498: 109-112.
60. Xu, J., J. Han, P. N. Epstein, and Y. Q. Liu. 2006. Regulation of PDK mRNA by high fatty acid and glucose in pancreatic islets. Biochem. Biophys. Res. Commun. 344: 827-833.
61. Diaz-Ruiz, R., M. Rigoulet, and A. Devin. 2011. The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 1807: 568-576.
62. Guppy, M., E. Greiner, and K. Brand. 1993. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 212: 95-99.
63. Monteleone, I., M. Sarra, F. Pallone, and G. Monteleone. 2012. Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr. Mol. Med. 12: 592-597.
64. Mease, P. J., I. B. McInnes, B. Kirkham, A. Kavanaugh, P. Rahman, D. van der Heijde, R. Landewé, P. Nash, L. Pricop, J. Yuan, et al; FUTURE 1 Study Group. 2015. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N. Engl. J. Med. 373: 1329-1339.
65. Leppkes, M., C. Becker, I. I. Ivanov, S. Hirth, S. Wirtz, C. Neufert, S. Pouly, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, et al. 2009. RORgexpressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136: 257-267.
66. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
67. Rovedatti, L., T. Kudo, P. Biancheri, M. Sarra, C. H. Knowles, D. S. Rampton, G. R. Corazza, G. Monteleone, A. Di Sabatino, and T. T. Macdonald. 2009. Differential regulation of interleukin 17 and interferon g production in inflammatory bowel disease. Gut 58: 1629-1636.
68. Graham, D. B., and R. J. Xavier. 2013. From genetics of inflammatory bowel disease towards mechanistic insights. Trends Immunol. 34: 371-378.